Company Filing History:
4 out of 15,471 
3 out of 932 
1 out of 832,761 Years Active: 2001-2005
Title: Annette Bistrup: Innovator in Glycosylsulfotransferase Research
Introduction
Annette Bistrup is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of glycosylsulfotransferases, with a total of 5 patents to her name. Her work focuses on the development of novel polypeptides and nucleic acid compositions that have important applications in research and therapeutic settings.
Latest Patents
Among her latest patents is the invention of Glycosyl sulfotransferase-3, which is a novel human glycosylsulfotransferase expressed in high endothelial cells (GST-3). This invention includes polypeptides and nucleic acid compositions that are useful in various applications, including research, diagnostics, and therapeutic agent screening. Additionally, she has developed methods for inhibiting selectin-mediated binding events and treating disease conditions associated with these processes. Another significant patent is HEC-G1CNAC6ST, which pertains to mammalian glycosylsulfotransferases expressed in high endothelial cells. This invention also includes polypeptides and nucleic acid compositions with similar applications in diagnostics and therapeutics.
Career Highlights
Annette Bistrup has worked with esteemed organizations such as the University of California and Syntex (U.S.A.) Inc. Her career has been marked by a commitment to advancing scientific knowledge and developing innovative solutions in her field.
Collaborations
Throughout her career, Annette has collaborated with notable colleagues, including Steven D. Rosen and Stefan Hemmerich. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Annette Bistrup is a distinguished inventor whose work in glycosylsulfotransferases has paved the way for advancements in research and therapeutic applications. Her contributions continue to impact the scientific community positively.